
Niraparib Extends Life for Mesothelioma Patients, NERO Trial Finds
The NERO study (Niraparib Efficacy in Patients With UnResectable MesotheliOma) investigated how well niraparib (brand name Zejula®) works to treat mesothelioma, a rare and aggressive cancer caused by asbestos exposure. The clinical trial was conducted by …